methadone

GPTKB entity

Statements (53)
Predicate Object
gptkbp:instanceOf opioid medication
gptkbp:administeredBy oral route
intravenous route
gptkbp:ATCCode gptkb:N07BC02
gptkbp:brand gptkb:Dolophine
gptkb:Methadose
gptkbp:broadcastOn gptkb:Schedule_II_(US)
gptkbp:CASNumber gptkb:76-99-3
gptkbp:chemicalClass diphenylheptane
gptkbp:contraindication acute asthma
paralytic ileus
severe respiratory depression
gptkbp:developedBy gptkb:Germany
gptkbp:discoveredBy gptkb:Gustav_Ehrhart
gptkb:Max_Bockmühl
gptkbp:discoveredIn 1937
gptkbp:eliminatedIn urine
gptkbp:excretion kidneys
gptkbp:halfLife 8-59 hours
gptkbp:hasMolecularFormula C21H27NO
https://www.w3.org/2000/01/rdf-schema#label methadone
gptkbp:interactsWith gptkb:beer
gptkb:benzodiazepines
other CNS depressants
gptkbp:IUPACName 6-(dimethylamino)-4,4-diphenylheptan-3-one
gptkbp:legalStatus off-patent
controlled substance
gptkbp:marketedAs 1947
gptkbp:mechanismOfAction NMDA receptor antagonist
mu-opioid receptor agonist
gptkbp:meltingPoint 235°C (hydrochloride)
gptkbp:metabolism liver
gptkbp:pregnancyCategory C (US)
gptkbp:PubChem_CID 4095
3953
gptkbp:riskOfDependence high
gptkbp:riskOfOverdose high
gptkbp:sideEffect constipation
sweating
QT prolongation
drowsiness
respiratory depression
gptkbp:solubility soluble in water (hydrochloride)
gptkbp:synonym gptkb:Amidon
gptkb:Symoron
Heptadon
gptkbp:UNII U76SF2399M
gptkbp:usedFor pain management
opioid dependence treatment
gptkbp:WHOModelListOfEssentialMedicines yes
gptkbp:bfsParent gptkb:IG_Farben
gptkb:CYP3A4
gptkbp:bfsLayer 5